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1. Introduction 
An approach as been proposed for cloning and 
expression of chemically synthesized genes in 
Escherichia coli cells [I] in which the synthetic 
poiynucleotide coding for the desired amino acid 
sequence was introduced into a specially designed 
plasmid near the end of the fl-galactosidase g ne, The 
synthetic gene contained an additional codon for 
methionine, which connected the /3-galactosidase 
protein chain with the peptide coded. The peptide 
can be split off this chimeric protein by cyanogen 
bromide treatment. Potency of this method was 
addition~y demonstrated by cloning of the synthetic 
genes for insulin [2] and neuropeptide l ucine- 
encephalin [3]. 
We used this principle to clone and express the 
synthetic gene for angiotensin 1. For this purpose, 
a 4%membered bihelical angiotensin 1polynucleotide 
was obtained by a combination of chemical and 
enzymatic methods: 
MetArpArgValTyrIleHisProPheHisLeuStop 
r--A--B--C ---7yA- 
TGAATTCATGGACCGTGTTTACATCCATCCTTTCCATTTGTGAATTCA __-I--___-I- 
ACTTAAGTACCTGGCACAAATGTAGG!J!AGGAAAGGTAAACACTTAAGT 
-A---D -r-E----A- 
A-F are chemically synthesized oligonuclotides. 
This gene was cloned in two vectors (in a plasmid and 
in a phage) and efficiencies of expression were com- 
pared. The specially designed pMRl and phage 
XplacS-1 [4] were used and expression i  the latter 
appeared to be -lo-times more efficient than in the 
former. We used the phosphatase method [S] for 
insertion of the synthetic gene into the plasmid 
~Isevier~~ort~-~otiand Biomedical Press 
vector. The techniques appeared to be very conve- 
nient in our hands and provided -100% yield of 
hybrid clones. 
The hormone preparation obtained exhibited 
physiological ctivity in vivo. 
2. Materials and methods 
Restriction endonuclease EcoRI was isolated 
according to [6]; DNA-ligase and polynucleotide 
kinase were isolated according to [7]; alkaline phos- 
phatase BAPF was purchased from Worthington 
(USA). 
hpiacfj DNA was kindly given by Dr T. G. Maximova 
and DNA of vector hpiac5-I [4] was isolated accord- 
ing to [8]. pBR322 DNA isolated from E. coli C600 
cells transformed by this plasmid [9]. 
Ligation of oligonucleotide blocks was performed 
essentially according to [ 11. The product was isolated 
by gel-filtration on Sephadex G-50 in 0.05 M triethyl- 
ammo~um bic~bonate and final puri~cation was 
achieved by preparative gel-electrophoresis on 20% 
polyacrylamide gel. 
The octanucleotide ‘linkers’ were added as in [lo]. 
The product after treatment with EcoRI was isolated 
by gel-filtration as described above and analyzed by 
gel-electrophoresis. 
2.1. Design of the ~~ffsrni~ vector 
A mixture of pBR322 plasmid and XpfacS DNAs 
was hydrolyzed sequentially by restriction endonu- 
cleases EcoRI and Hind111 and after the removal of 
these enzymes was ligated by DNA-ligase. The DNA 
obtained was used to transform CaClz-treated E. coli 
cells BMH7 l-1 8 (A &zcpro]F’ lac 1% AM1 5 Pro+> 
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[I 1 ,I 21 and the tr~sform~ts plated on I .5% meat- 
peptone agar containing ampicillin (20 pg/ml), 
S-bromo4chloroindolyl-/3-D-galactoside (X-gal, 
20 yg/ml) and isopropylthiogalactoside (IPTG, 
5 X lOa M). Cells of one of the blue clones were 
grown and their plasmid DNA was isolated as above 
described. 
2.2. Insertion of the syntheti& polynffcle~tide into 
plusmid DNA 
Hybrid plasmid DNA (2 pg) was treated by EcoRI 
and dephosphorylated byE. coli phosphatase accord- 
ing to [S]. Phosphatase was thoroughly removed by 
3 phenol extractions, the DNA precipitated and 
washed with ethanol. The precipitate was dissolved 
in 20 ~1 ligase buffer [lo] and divided into two equal 
parts. To one part (experiment) 5pmol ‘linkered’ 
synthetic polynucleotide was added and both parts 
diluted with water to 20 ~1. The mixtures were 
cooled to 4”C, and 1 activity unit of DNA-ligase was 
added to each of them. These preparations were used 
for transformation of CaClz-treated E. culi BMH7 1-l 8 
in 12 h incubation, and the transformants were 
plated on meat-peptone agar containing ampicillin 
(20 @g/ml). Cells of 10 experimental clones were 
grown in ~pic~lin-supplemented L-broth, collected, 
treated with cyanogen bromide in formic acid [I] 
and the lysates tested by radioimmunoanalysis for 
angiotensin 1, using a Clinical Assay (USA) kit 
according to the protocol enclosed. 
2.3. Insertion of synthetic polynucleotide into DNA 
of XplacS-1 
XplacS-1 DNA (1 Erg) treated by EcoRI was mixed 
with 1 pmol synthetic polynucleotide and 0.5 activity 
units of DNA-ligase in 10 gl ligase buffer [lo] and 
this mixture was kept for 12 h at 4°C. The DNA 
obtained was used for transfection of E. co& 
BMH7 l-1 8 as in [ 131. The cells were plated on meat- 
peptone agar containing X-gal and IPTG. Recom- 
binant clones giving colourless plaques were grown 
and used to infect E. coli BMW7 l-l 8. The cells were 
collected 30 min after infection and assayed for 
angiotensin 1as above. 
3. Results and discussion 
3 .l . Synthesis and ligation of oligonucleotide blocks 
The synthesis of oligonucleotides A-F was per- 
formed using a modification f the triester method 
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[ 141 from the correspond~g d~ucleotide blocks. 
The primary structures of all the oligonucleotides 
were confirmed by Sanger techniques [ 151. 
The oligonucleotides B-F were phosphorylated by 
polynucleotide kinase, purified by hip-performance 
liquid chromatography, and joined into a bihelical 
polynucleotide by means of T4 DNA-ligase. The 
fidelity of joining was checked by sequencing using 
the Maxam-Gilbert procedure [161. The polynucleo- 
tide duplex B-F was purified by preparative gel- 
electrophoresis, and flanked by the linker oligonu- 
cleotide A using DNA-ligase. Treatment of the prod- 
uct of this reaction by EcoRI afforded the bihelical 
polynucleotide with prot~d~g EcoRI sticky ends. 
Details of the chemical synthesis wil be published 
elsewhere. 
3.2. Design of the ~lasmid vector 
To clone and to express the synthetic gene of 
angiotensin 1we constructed the plasmid pMR1 
incorporating the main part of the gene of E. coli 
~-g~actosidase; pMR1 was made by a single-stage 
procedure from DNAs of the plasmid pBR322 and 
of hplac.5 phage. It is known [ 171, that combined 
cleavage of hplac.5 DNA by EcoRI and Hind111 
affords a mixture of fragments one of which contains 
the operator zone and 30 1.5 base residues of the 
structural part of the P-galactosidase g ne. DNA of 
pBR322 plasmid contains a single site for each of 
EcoRI and HindIII; the latter site resides in the 
promotor egion of the tetracycline operon 191. 
Hence, ligation of the mixture of EcoRI t Hind111 
fragments of hplac.5 and pBR322 afforded recom- 
binant molecules. Recombinant clones were identi- 
fied by their ability to form blue colonies when 
grown on a medium with X-gal and IPTG. Plasmid 
DNA of one such clone was isolated and character- 
ized by restriction analysis (fig.1). Hydrolysis by 
either EcoRl, or Hind111 afforded a single product 
of -6 Mdaltons, whereas combined hydrolysis gives 
two products of 2.6 and 3.8 Mdahons. The first 
fragment corresponds to the plasmid part of the 
vector, the second one to the gene of @galactosidase. 
E. coli BMH7 l-l 8 cells transformed by this plasmid 
are resistant to ampicillin and produce active /I-galac- 
tosidase. 
3.3. Inte~ation of the synthetic gene into the 
plasmid vector 
The synthetic gene of angiotensin 1was inserted 
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Fig.1. Gel-electrophoresis of pMRl plasmid DNA digested by 
EcoRI and Hind111 restriction endonucleases. Lanes (1,6) 
EcoRI hydrolysate of AC1857 DNA(markers). Lanes (2-4) 
hydrolysates of pMR1 DNA: (2) EcoRI; (3) HindID; (4) 
EcoRI + HindIII. Lane (5) EcoRI hydrolysate of pBR322 
DNA. Electrophoresis was run in 1% agarose gel for 4 h at 
60 V. 
into plasmid pMR1 at the site of hydrolysis by 
restriction endonuclease EcoRI. Transformants 
having the hybrid and the starting plasmids were 
expected to be phenotypically identical. Therefore 
it was necessary to increase the yield of hybrid clones 
to a maximum in order to select them directly on 
the basis of their ability to produce angiotensin 1. 
Hence, we employed the method of molecular selec- 
tion [5]. DNA of pMR1 plasmid was treated by 
restriction nuclease EcoRI and subsequently by 
alkaline phosphatase, and introduced into DNA 
ligasecatalyzed reaction with the linkered synthetic 
gene. This procedure must give circular DNA only 
with hybrid molecules containing the synthetic 
sequence. It is known that plasmid DNA in a linear 
form has a much smaller transforming activity than 
in the circular form and thus hybrid plasmids obtain 
a great advantage. Hybrid DNA obtained by the 
above procedure was used to transform E. coli 
BMH7 l-l 8, and the cells plated on meat-peptone 
agar with ampicillin. The experiment gave 205 clones, 
controls which omitted the synthetic gene gave no 
transformants. Cells of 10 clones were grown on a 
medium containing IPTG, treated with cyanogen 
bromide in formic acid [ 11, and assayed for angio- 
tensin 1 by radioimmunoanalysis (fig.2a). It is seen, 
that the content of irnmunoreactive materials in the 
products of clones 1,2,5,9 and 10 is significantly 
0 12 3L 5 67 8 910 (2345678 
Fig.2. Radioimmunoanalysis of cell lysates for angiotensin 1 
content. (a) Clones with the recombinant plasmid; (0) con- 
trol, clone with the starting plasmid pMR1. (b) Cells infected 
by clones of the recombinant phage. 
greater than in the control. It is noteworthy that the 
relative amount of the labelled hormone displaced by 
the product of clone 9 strongly depends on the 
amount of this product added, whereas no such 
dependence was found with the control. Content of 
angiotensin 1 in the product of clone 9 is -300 pg/108 
cells. 
3.4. Integration of the synthetic gene into phage vector 
The level of expression of inserted fragments is in 
some cases greater with phage vectors as compared 
to plasmids. Therefore we attempted also to intro- 
duce the synthetic angiotensin 1 gene into DNA of 
vector phage hplac5-1 [4]. This DNA has a single 
EcoRI site within the gene of /3-galactosidase. Inser- 
tions at this site are easily identified because hybrid 
phages form colourless plaques on a medium con- 
taining X-gal and IPTG. 
The DNA of phage hplacS-1 was cleaved by 
EcoRI, ligated with the synthetic angiotensin 1 gene, 
and the resulting material used to transfect E. cofi 
BMH7 l-1 8. About 15% of the phages produced 
colourless plaques on meat-peptone agar containing 
X-gal and IPTG. We studied the ability of 8 such 
clones to produce angiotensin 1. To this purpose, 
phages of the clones were grown and the resulting 
progeny used to infect E. coli BMH7 l-1 8 at a multi- 
plicity of 10. The infected cells were collected 30 min 
after infection, treated with cyanogen bromide in 
formic acid, and the presence of angiotensin 1 in the 
lysates tested for by radioimmunoanalysis (fig2b). It 
is seen that the content of immunoreactive materials 
in clones 1,4 and 5 is much greater than in the other 
clones. 
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The average production of angiotensin 1in such 
infected cells was ome IO-times greater than in cells 
bearing the above hybrid plasmid. Presumably, this is 
due to the higher dose of angiotensin 1gene in cells 
infected by the hybrid phage. It is known, that E. coli 
cells in the middle of the log-phase contain some 
20-30 copies of the plasmid ColEl and of related 
plasmid pBR-series [9], whereas phage-infected cell 
contains ome 100 copies of phage DNA molecules. 
hydr.pr.,mm 
i i f iiii5 t 
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Noteworthy is also the fact that about a half of 
the recomb~~ts obtained are producers of angio- 
tensin 1. Presumably, this is due to the two possible 
orientations of the inserted synthetic gene having 
identical sticky ends on both sides. Only one orienta- 
tion of these two results in correct addition of the 
codogenic strand of the synthetic gene to the 
codogenic hain of ~-g~actosidase. 
Fig.3. Effect of angiotensin 1 produced by clone 9 (tig.1) on 
the arterial pressure of rat. The times of injection of the 
tested preparations are indicated by the arrows. (1) Physio- 
logical solution; (2) 2.5 ng authentic angiotensin 1; (3) con- 
trol, 20 ~1 lysate of cells having the start& plasmid pMR1; 
(4-6) 5,lO and 20 ~1, respectively, of lysate of clone 9. 
The identical sticky ends of the synthetic gene 
promote formation of oligomers, and the orientation 
of monomeric units in such oligomers may be ran- 
dom. However, translation of chimeric mRNA in 
recombinant clones containing oligomeric gene must 
stop within the first monomer unit because there are 
nonsensecodons atthe ends of both the codogenic 
and the noncodogenic strands. Therefore, recom- 
binant clones contain~g oligomeric synthetic gene 
may also produce angiotensin 1at a probability of 
50%. 
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